Coverage
Filings
Danish vaccine maker Bavarian Nordic will supply an undisclosed European country with its smallpox and mpox vaccine under a new contract valued at over 200 million Danish Krone, the company announced Wednesday.
Danish vaccine company Bavarian Nordic has entered an agreement to sell a Priority Review Voucher for a total of $160 million, the company said Wednesday.
| 24 Apr 2013 |
| Bavarian Nordic A/S - Report on the Results of the Annual General Meeting, held 17 April 2013 | 17 Apr 2013 |
| Bavarian Nordic Receives Contract Valued up to USD 228 Million from the U.S. Government Securing Continued Production and Deliveries of IMVAMUNE® Smallpox Vaccine | 16 Apr 2013 |
| Bavarian Nordic Agrees on Interim Analysis with the FDA and Provides an Update on its PROSPECT Phase 3 Trial | 8 Apr 2013 |
| Bavarian Nordic A/S - Notice Convening Ordinary General Meeting | 19 Mar 2013 |